慢性选择性内皮素A受体拮抗作用可降低高血压慢性肾病患者的血清尿酸水平。 - Suppr

Suppr

超能文献

Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.

作者信息

Dhaun Neeraj, Johnston Neil R, Goddard Jane, Webb David J

出版信息

Hypertension. 2011 Aug;58(2):e11-2. doi: 10.1161/HYPERTENSIONAHA.111.175646. Epub 2011 Jun 27.

DOI:10.1161/HYPERTENSIONAHA.111.175646

PMID:21709210

Abstract

摘要

相似文献

Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.慢性选择性内皮素A受体拮抗作用可降低高血压慢性肾病患者的血清尿酸水平。

Hypertension. 2011 Aug;58(2):e11-2. doi: 10.1161/HYPERTENSIONAHA.111.175646. Epub 2011 Jun 27.

Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.选择性内皮素 A 受体拮抗剂可减少慢性蛋白尿肾病患者的蛋白尿、血压和动脉僵硬。

Hypertension. 2011 Apr;57(4):772-9. doi: 10.1161/HYPERTENSIONAHA.110.167486. Epub 2011 Feb 28.

Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.慢性肾脏病患者以及选择性内皮素A受体拮抗治疗后，血浆前内皮素-1肽浓度升高。

J Am Heart Assoc. 2015 Mar 23;4(3):e001624. doi: 10.1161/JAHA.114.001624.

High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease.高尿酸水平与慢性肾脏病患者肾小球滤过率下降相关。

J Med Assoc Thai. 2010 Nov;93 Suppl 6:S65-70.

Relationship between hyperuricemia and chronic kidney disease.高尿酸血症与慢性肾脏病的关系。

Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1039-44. doi: 10.1080/15257770.2011.611484.

Relief of chronic neuropathic pain through endothelin antagonism.通过内皮素拮抗作用缓解慢性神经性疼痛。

Am J Med. 2010 Mar;123(3):e7. doi: 10.1016/j.amjmed.2009.07.025.

Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.内皮素-A受体拮抗作用可降低慢性肾衰竭高血压患者的血压并增加肾血流量：选择性与联合内皮素受体阻断的比较

Circulation. 2004 Mar 9;109(9):1186-93. doi: 10.1161/01.CIR.0000118499.69469.51. Epub 2004 Feb 23.

Diabetes: Lowering serum uric acid levels to prevent kidney failure.糖尿病：降低血清尿酸水平以预防肾衰竭。

Nat Rev Nephrol. 2011 Aug 2;7(9):495-6. doi: 10.1038/nrneph.2011.107.

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.使用西他生坦选择性拮抗内皮素A受体治疗与结缔组织病相关的肺动脉高压。

Ann Rheum Dis. 2007 Nov;66(11):1467-72. doi: 10.1136/ard.2007.069609. Epub 2007 May 1.

Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.氯沙坦与坎地沙坦对利尿剂相关高血压和高尿酸血症患者尿酸、肾功能及纤维蛋白原的影响

Am J Hypertens. 2006 Feb;19(2):208-13. doi: 10.1016/j.amjhyper.2005.08.005.

引用本文的文献

Endothelin receptor antagonists for pulmonary arterial hypertension.内皮素受体拮抗剂治疗肺动脉高压。

Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD004434. doi: 10.1002/14651858.CD004434.pub6.

Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension.随机双内皮素受体拮抗剂阿普西特坦治疗高血压的剂量反应研究。

Hypertension. 2020 Apr;75(4):956-965. doi: 10.1161/HYPERTENSIONAHA.119.14504. Epub 2020 Feb 17.

A novel role for myeloid endothelin-B receptors in hypertension.髓样内皮素 B 受体在高血压中的新作用。

Eur Heart J. 2019 Mar 1;40(9):768-784. doi: 10.1093/eurheartj/ehy881.

Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease.在实验性肾血管疾病中使用马昔腾坦对内皮素A和B受体进行慢性阻断。

Nephrol Dial Transplant. 2015 Apr;30(4):584-93. doi: 10.1093/ndt/gfu361. Epub 2014 Nov 21.

Endothelin, kidney disease, and hypertension.内皮素、肾脏疾病与高血压。

Hypertension. 2013 Jun;61(6):1142-5. doi: 10.1161/HYPERTENSIONAHA.113.00595. Epub 2013 Apr 22.

Endothelin receptor antagonists for pulmonary arterial hypertension.用于治疗肺动脉高压的内皮素受体拮抗剂。

Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD004434. doi: 10.1002/14651858.CD004434.pub5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验